As of Aug 25
| -0.01 / -0.11%|
The 6 analysts offering 12-month price forecasts for GenMark Diagnostics Inc have a median target of 12.50, with a high estimate of 13.00 and a low estimate of 10.00. The median estimate represents a +43.02% increase from the last price of 8.74.
The current consensus among 7 polled investment analysts is to Buy stock in GenMark Diagnostics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.